Sumatriptan News and Research

RSS
Triptans better at relieving migraine pain than recently marketed and more expensive drugs

Triptans better at relieving migraine pain than recently marketed and more expensive drugs

Triptans prove to be more effective for acute migraines than newer drugs

Triptans prove to be more effective for acute migraines than newer drugs

Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks

Study finds top three classes of medications more effective than ibuprofen for treating migraine attacks

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

New AAN guidelines includes recommendations for treatment of migraine in children, teens

New AAN guidelines includes recommendations for treatment of migraine in children, teens

New drug for migraine in the pipeline

New drug for migraine in the pipeline

GammaCore both effective and cost effective for the treatment of cluster headache

GammaCore both effective and cost effective for the treatment of cluster headache

FDA approves Lannett's ANDA for Sumatriptan Nasal Spray USP

FDA approves Lannett's ANDA for Sumatriptan Nasal Spray USP

FDA approves ZEMBRACESymTouch (sumatriptan succinate) injection for treatment of acute migraines

FDA approves ZEMBRACESymTouch (sumatriptan succinate) injection for treatment of acute migraines

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

Charleston Laboratories begins Phase 1 study on CL-H1T migraine drug candidate

Presentation at International Headache Congress shows electroCore’s chronic cluster headache treatment to be cost-effective

Presentation at International Headache Congress shows electroCore’s chronic cluster headache treatment to be cost-effective

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

AHS provides updated assessment of treatments for acute migraine

AHS provides updated assessment of treatments for acute migraine

FDA issues Complete Response letter for Avanir’s AVP-825 NDA

FDA issues Complete Response letter for Avanir’s AVP-825 NDA

Avanir Pharmaceuticals to publish AVP-825 phase III study results in the journal 'Headache'

Avanir Pharmaceuticals to publish AVP-825 phase III study results in the journal 'Headache'

Endo acquires worldwide rights to Zogenix' sumatriptan injection

Endo acquires worldwide rights to Zogenix' sumatriptan injection

FDA accepts AVP-825 NDA for acute treatment of migraine

FDA accepts AVP-825 NDA for acute treatment of migraine

Migraine severity and adiponectin: an interview with Dr. B. Lee Peterlin, Johns Hopkins University School of Medicine

Migraine severity and adiponectin: an interview with Dr. B. Lee Peterlin, Johns Hopkins University School of Medicine

Migraine severity may be predicted by blood levels of fat cell hormone

Migraine severity may be predicted by blood levels of fat cell hormone

Strong placebo response key to adolescent migraine trial failures

Strong placebo response key to adolescent migraine trial failures

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.